What is PHCUF stock price today?

PHCUF (Photocure ASA) stock is trading at $7.07 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is PHCUF stock going up or down today?

PHCUF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PHCUF stock now?

The decision to buy PHCUF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PHCUF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PHCUF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PHCUF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if PHCUF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is PHCUF's P/E ratio?

P/E ratio data for PHCUF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is PHCUF's market cap?

PHCUF (Photocure ASA) has a market capitalization of $0.19 billion, making it a small-cap stock.

What is PHCUF's price to book ratio?

PHCUF trades at a price-to-book (P/B) ratio of 3.71, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does PHCUF pay dividends?

PHCUF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PHCUF's dividend yield?

PHCUF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PHCUF stock a good long-term investment?

PHCUF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PHCUF's revenue growth rate?

PHCUF has shown revenue growth of -0.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

PHCUF is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in PHCUF?

Key risks for PHCUF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PHCUF compare to its competitors?

Compare PHCUF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PHCUF's performance and positioning.

What is PHCUF's stock price target for 2026?

Our AI model provides price targets for PHCUF based on fundamental analysis: Bull case $9.19 (+30%), Base case $8.13 (+15%), Bear case $6.36 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about PHCUF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PHCUF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PHCUF's next earnings report?

PHCUF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PHCUF - Photocure ASA

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$7.07

+$0.00 (+0.00%)

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreement with Richard Wolf GmbH to develop and commercialize a 4K LED high-definition reusable blue light cystoscope based on Richard Wolf's System blue technology. It sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. The company operates in the Nordic countries, Germany, France, Austria, the United Kingdom, the Benelux, Italy, rest of the Europe, Canada, and the United States. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.

PHCUF Key Statistics

Market Cap

$191.02M

P/B Ratio

3.71

EPS

$-0.01

Revenue Growth

-0.0%

Profit Margin

-0.0%

Employees

102

How PHCUF Compares to Peers

PHCUF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PHCUF(This stock)	$191.02M	N/A	-0%	-0.0%	-
LLYEli Lilly	$819.79B	40.0	0%	0.3%	vs LLY
JNJJohnson &	$555.22B	26.7	0%	0.2%	vs JNJ
PFEPfizer Inc	$151.71B	19.6	-0%	0.1%	vs PFE
MRKMerck &	$283.10B	15.7	0%	0.3%	vs MRK
ABBVAbbvie Inc	$355.43B	84.8	0%	0.1%	vs ABBV

Photocure ASA Company Information

Headquarters: Hoffsveien 4, Oslo, Norway, 0275, undefined
Website: www.photocure.com
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

About Photocure ASA

PHCUF Key Statistics

How PHCUF Compares to Peers

Photocure ASA Company Information

Upcoming Events for PHCUF